AbbVie announces new European approval for VENCLYXTO combination
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novartis" CAR-T Therapy Kymriah Gets Approval in Europe
Novartis (NVS) gets EC approval for CAR-T therapy, Kymriah, for the treatment of pediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukemia. Novartis AG NVS announced that the European Commiss.....»»
FDA Approves Roche Subsidiary"s Treatment for Acute Myeloid Leukemia
Venclexta was developed in partnership with AbbVieRelated Stocks: ABBV, RHHBY,.....»»
Cancer Research Highlight: AbbVie And Pfizer Blitz Acute Myeloid Leukemia
Cancer Research Highlight: AbbVie And Pfizer Blitz Acute Myeloid Leukemia.....»»
Roche announces European Commission approves Venclyxto-based combinations
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aprea Therapeutics gets FDA orphan drug designation for acute myeloid leukemia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Curis receives FDA orphan drug designation for acute myeloid leukemia treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Curis announces FDA orphan drug designation for acute myeloid leukemia treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Roche announces European Commission approval of Evrysdi
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marker Therapeutics" Acute Myeloid Leukemia candidate designated Orphan Drug
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Syndax treatment of acute myeloid leukemia granted FDA orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie receives EC approval of VENCLYXTO combination regimen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie, Allergan receive final European approval for merger
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie announces European Commission approval of Rinvoq
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aslan soars 186% after journal reports new acute myeloid leukemia data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca shares rise on early U.S. approval for leukemia drug
AstraZeneca shares rose 2.7% on Friday after the British drugmaker won earlier-than-expected U.S. regulatory approval for a leukemia drug, in a challenge to rival AbbVie ......»»
Trovagene completes Phase 1b trial of onvansertib in Acute Myeloid Leukemia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen granted orphan status for Acute Myeloid Leukemia treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Roche announces European approval for Tecentriq plus Abraxane for breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Washington University gets $15M grant to study leukemia
Washington University investigators at Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine have been awarded a $15 million grant to study the genetic changes that drive acute myeloid leukemia (AML), a deadly blood cancer. F.....»»